Peritoneal Dialysis Use and Practice Patterns: an International Survey Study.
Yeoungjee Cho,Aminu K. Bello,Adeera Levin,Meaghan Lunney,Mohamed A. Osman,Feng Ye,Gloria E. Ashuntantang,Ezequiel Bellorin-Font,Mohammed Benghanem Gharbi,Sara N. Davison,Mohammad Ghnaimat,Paul Harden,Htay,Vivekanand Jha,Kamyar Kalantar-Zadeh,Peter G. Kerr,Scott Klarenbach,Csaba P. Kovesdy,Valerie Luyckx,Brendon Neuen,Donal O'Donoghue,Shahrzad Ossareh,Jeffrey Perl,Harun Ur Rashid,Eric Rondeau,Emily J. See,Syed Saad,Laura Sola,Irma Tchokhonelidze,Vladimir Tesar,Kriang Tungsanga,Rumeyza Turan Kazancioglu,Angela Yee-Moon Wang,Chih-Wei Yang,Alexander Zemchenkov,Ming-Hui Zhao,Kitty J. Jager,Fergus J. Caskey,Kailash K. Jindal,Ikechi G. Okpechi,Marcello Tonelli,David C. Harris,David W. Johnson
DOI: https://doi.org/10.1053/j.ajkd.2020.05.032
IF: 11.072
2021-01-01
American Journal of Kidney Diseases
Abstract:Rationale & Objective: Approximately 11% of people with kidney failure worldwide are treated with peritoneal dialysis (PD). This study examined PD use and practice patterns across the globe. Study Design: A cross-sectional survey. Setting & Participants: Stakeholders including clinicians, policy makers, and patient representatives in 182 countries convened by the International Society of Nephrology between July and September 2018. Outcomes: PD use, availability, accessibility, affordability, delivery, and reporting of quality outcome measures. Analytical Approach: Descriptive statistics. Results: Responses were received from 88% (n = 160) of countries and there were 313 participants (257 nephrologists [82%], 22 nonnephrologist physicians [7%], 6 other health professionals [2%], 17 administrators/policy makers/civil servants [5%], and 11 others [4%]). 85% (n = 156) of countries responded to questions about PD. Median PD use was 38.1 per million population. PD was not available in 30 of the 156 (19%) countries responding to PD-related questions, particularly in countries in Africa (20/41) and low-income countries (15/ 22). In 69% of countries, PD was the initial dialysis modality for <= 10% of patients with newly diagnosed kidney failure. Patients receiving PD were expected to pay 1% to 25% of treatment costs, and higher (>75%) copayments (out-of-pocket expenses incurred by patients) were more common in South Asia and low-income countries. Average exchange volumes were adequate (defined as 3-4 exchanges per day or the equivalent for automated PD) in 72% of countries. PD quality outcome monitoring and reporting were variable. Most countries did not measure patient-reported PD outcomes. Limitations: Low responses from policy makers; limited ability to provide more in-depth explanations underpinning outcomes from each country due to lack of granular data; lack of objective data. Conclusions: Large inter- and intraregional disparities exist in PD availability, accessibility, affordability, delivery, and reporting of quality outcome measures around the world, with the greatest gaps observed in Africa and South Asia.